Benzyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazine-2(1H)-carboxylate

Catalog No. :
ACQBCI653
CAS No. :
2924825-34-1
Molecular Formula :
C24H28BN3O4
Molecular Weight :
433.32

IUPAC Name:benzyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazine-2(1H)-carboxylate

Benzyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazine-2(1H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazine-2(1H)-carboxylate
IUPAC Namebenzyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazine-2(1H)-carboxylate
Molecular FormulaC24H28BN3O4
Molecular Weight433.32
SMILESO=C(N1CC2=NC3=CC=C(B4OC(C)(C)C(C)(C)O4)C=C3N2CC1)OCC5=CC=CC=C5
InChI KeyGJTKJTHYBPDAPA-UHFFFAOYSA-N
SynonymBenzyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazine-2(1H)-carboxylate;Pyrazino[1,2-a]benzimidazole-2(1H)-carboxylic acid, 3,4-dihydro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, phenylmethyl ester
CAS No.2924825-34-1

Synthetic Route by SureRoute

1. ACQBCI653 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQBCI653 route product structure diagram
    ACQBCI6532924825-34-1
Inquiry

2. ACQBCI653 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQBCI653 route product structure diagram
    ACQBCI6532924825-34-1
Inquiry

Comments (0)